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ABSTRACT 
Background: Early detection of psychosis is an important issue in current research. Early 
intervention helps to improve the outcome of the disorder. Therefore, a comprehensive 
examination in large populations, necessary as it might be, is economically almost not 
feasible. A screening via self-report is more practicable as it helps focus on individuals with 
high symptom loads.  
Aim: To examine aspects of validity of the Selfscreen-Prodrome (SPro) as a new screening 
tool for prodromal states of psychosis in a military sample.  
Method: 938 Swiss conscripts were assessed with the SPro, the Eppendorf Schizophrenia-
Inventory (ESI) and the Symptom Checklist-90-Revised (SCL-90-R). Conscripts with 
potential psychosis-like pathology (T-transformed Severity Index of the SCL-90-R-subscales 
Psychoticism [PSYC] and Paranoid Ideation [PAR] ≥63) were compared with those not 
meeting the criteria of this condition (non-cases). 
Results: Both groups (cases and non-cases) showed significant differences in their mean 
scores on SPro and ESI, although only the SPro had satisfactory effect sizes. In hierarchic 
logistic regression models the SPro turned out to be highly predictive for caseness while ESI 
scales were not significant. A cut-off score of ≥2 on the Spro subscale for psychotic risk 
(SPro-Psy-Risk) was found to identify caseness best with a sensitivity of 74% and a 
specificity of 61%. 
Conclusion: The SPro has proven to be a valid and very economic screening tool for general 
and prodromal pathology in large populations. 
 
 
Keywords: prodromes; psychosis; screening; early detection; self-rating; validation; general 
population 
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1. Introduction 
 In current research and practice there is a growing interest in identifying an incipient 
psychosis at a very early stage (prodrome), as early intervention can improve the course of the 
disorder (for review see Bota et al., 2008; Harrigan et al., 2003; Resch, 2008; Riecher-Rössler 
et al., 2006; Serretti et al., 2009). A psychotic disorder mostly announces itself years before 
the first episode, in the so-called prodromal state, with unspecific signs and functional 
impairment. A prodrome is defined by symptoms preceding the clinical manifestation of a 
disorder (Yung and McGorry, 1996a). Unspecific symptoms such as concentration and 
attention difficulties, sleep disturbances, depression, anxiety, derealization and 
depersonalization are reported as early signs/prodromes of the disorder (Loewy et al., 2005; 
Olsen and Rosenbaum, 2006; Riecher-Rössler et al., 2006). Even in early unspecific states, 
the disorder may lead to serious consequences for individuals concerned (Riecher-Rössler et 
al., 2006). With an onset mostly in adolescence and young adulthood, relevant developments 
and achievement of social roles often are impaired. Delayed diagnosis and treatment is 
associated with a worse long-term prognosis, which might be minimized by early detection 
and intervention (Riecher-Rössler et al., 2006; Harrigan et al., 2003; Larsen et al., 2001; 
McGorry, 2002; Norman et al., 2001; Pelosi et al., 2003). However, especially in low 
incidence disorders such as schizophrenia, early diagnosis with clinical examinations such as 
a structured face-to-face interview of the general population would be much too extensive. A 
possible strategy is a stepwise process with an initial pre-screening via self-report and 
subsequent focus on individuals with higher risk.  
Individuals with psychotic disorders often show poor insight into their disease 
(McGorry and McConville, 2000). Therefore, it can be assumed that these individuals are not 
capable of reporting their symptoms properly. Furthermore, there is a strong body of evidence 
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for cognitive deficits in schizophrenia and even before the onset of psychosis (see e.g. 
Riecher-Rossler et al., 2009; Mesholam-Gately et al., 2009; Yung and McGorry, 1996b). 
Using a structured interview, Liraud et al. (2004) found high overlaps with self-reported 
positive and negative symptoms in acute psychotic patients. In self-reports in a community 
sample, Supina and Patten (2006) found lifetime prevalences of 0.9% of diagnosed 
schizophrenia or other psychoses, very similar to overall lifetime-rates of schizophrenic 
psychoses. Thus, it can be assumed that self-reports in individuals with psychosis are valid. 
Furthermore, individuals with prodromal states are usually not delusional and therefore 
should have enough insight into the illness to report their symptoms adequately (Lappin et al., 
2007).  
The challenge is to identify individuals who are at risk for psychosis as early as 
possible. In many cases, particularly in males, first onset occurs already before the age of 
twenty (Häfner et al., 1998b), so that early detection should start in late adolescence. The 
expense and effort of pre-selections via self-reports are disproportionately lower to extensive 
screening procedures using clinical interviews. 
The aim of this study was to evaluate a newly developed screening tool based on self-
ratings regarding its predictive validity for (pre-)psychotic experiences. We used the 
“Selfscreen-Prodrome” (SPro), a self-report questionnaire, designed for use as psychiatric 
screening instrument and originally developed in a study of early detection of psychosis 
(FrühErkennung von PSYchosen, FEPSY; Riecher-Rössler et al., 2007). In a first study the 
SPro turned out to be useful a) to separate mentally ill from healthy individuals, and b) to 
filter individuals with an at-risk mental state (ARMS) for psychosis from patients with other 
ICD-10-diagnoses for a further diagnostic process (Kammermann et al., 2009). 
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 The specific aim of this study was to examine the diagnostic validity of the SPro in a 
general population sample and to compare its predictive validity to an already existing 
measure for psychosis, the “Eppendorf-Schizophrenia-Inventory” (ESI; Mass et al., 2000), 
which is a well-known tool for diagnosing psychosis as well as prepsychotic states. We 
hypothesized that the SPro is an adequate tool for predicting psychiatric caseness and is more 
specific and useful for identifying psychotic experiences than the ESI. 
 
2. Methods 
Switzerland has compulsory military service for all male citizens. This means, independently 
of whether or not a Swiss man finally serves in the army, he is obliged by law to attend 
military recruitment with psychological and medical examinations. These pre-military 
examinations are generally conducted when conscripts are between 18 and 22 years old. The 
data used in this study originate from the extensive examinations of all conscripts of 
Switzerland prior to basic military training. Our study is part of this more comprehensive 
research project, which has been described in detail previously (Vetter et al., 2009). The use 
of anonymized information in these studies was cleared by the Zurich State Ethical 
Committee (KEK) to fulfill all legal and data privacy protection exigencies. 
Out of about 28,000 Swiss conscripts examined in 2002, 1,088 conscripts were 
randomly selected to complete additional paper-pencil-questionnaires containing the 
psychiatric screening-scales described below. Screening sessions were introduced and 
supervised by military test psychologists. Participants were informed twice, orally and with a 
fact sheet, about the research purpose of the psychometric testing. They had the choice to 
participate or not. Although everyone had to attend the test sessions with their platoon, they 
had the choice not to complete the questionnaire and to deposit empty papers at the end. 
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The study was conducted at the Medical Department of the Swiss Armed Forces in 
collaboration with the University of Zurich, Switzerland.  
 
2.1. Sample 
Of the initially selected 1,088 conscripts, 168 were excluded from the analysis for 
suspected malingering (Derogatis, 1977; for definition see SCL-90-R in the Instruments 
section below) and social desirability (Mass, 2001; for social desirability and survey 
motivation see ESI in the Instruments section below). Accordingly, 920 males with a mean 
age of 20.64 years (SD=0.97) were analyzed in this study.  
 
2.2. Instruments 
 The SPro (Kammermann et al., 2009) is a self-report instrument (see appendix) that 
consists of 32 items concerning highly frequent prodromal symptoms and risk indicators of an 
incipient psychosis, based on literature. The instrument covers attenuated psychotic 
symptoms such as ideas of being persecuted and recent unspecific symptoms typical for the 
prodrome, such as concentration difficulties, increased sensitivity, depressed mood and 
incipient changes in perception. A recently decreased level of functioning in different social 
roles (Riecher-Rössler, 1999) was found to be an important predictor of incipient psychosis in 
the ABC-study (Häfner et al., 1998a). In individuals with increased vulnerability, 
consumption of illegal drugs can trigger psychotic symptoms or serve as coping strategy in 
early psychosis and is therefore as a risk indicator.  Another indicator is a family history of 
mental disorders (Drewe et al., 2004). Questions are dichotomized and scored with 0 (“not 
true”) and 1 (“true”). Previous research has shown the SPro to perform sufficiently in a 
The Selfscreen Prodrome 
  
 
7 
clinical (Alpha=.90; Kammermann et al., 2009) and a conscript sample (Alpha=.89; Müller et 
al., 2009). In the present dataset the SPro has an Alpha of .87. 
In a study comparing individuals with an at-risk mental state (ARMS), psychosis-
(risk)-patients and healthy controls, six items of the SPro (depressive mood, concentration 
dysfunction, poor capacity, alteration of perception, to feel like being watched, affected or 
threatened, and mental disorders in kinship) were found highly predictive for identifying 
psychosis-(risk)-patients (Kammermann et al., 2009). Confirmed by discriminatory power 
analyses, these items were summarized to the subscale “risk for psychosis” (SPro-Psy-Risk; 
see appendix for specially marked items in the SPro-Total).  
The ESI (Mass, 2001) is a clinical measure for self-experienced disturbances in 
cognitive, linguistic, sensomotoric and coenesthetic (body misperceptions) domains as found 
in pre-psychotic states, i.e. in subjects with prodromal or attenuated psychotic symptoms as 
well as in schizophrenia patients. The ESI contains 40 items whereof 34 are combined to four 
scales: Attention and Speech Impairment (AS), Ideas of Reference (IR), Auditory Uncertainty 
(AU), and Deviant Perception (DP). Moreover, the ESI contains a five-item Frankness-scale 
(FR; score>2) to control for socially desirable tendencies and one item (item 40; score=0) 
assessing general survey motivation. While AS represents a mediating vulnerability factor, 
IR, AU, and DP are assumed to provide reversible indicators of psychotic exacerbations 
(Mass et al., 2005). ESI-items provide a four-point response format from “strongly disagree” 
(0) through “strongly agree” (3), which are summarized to the mentioned subscale-scores. 
The SCL-90-R (Derogatis, 1977) is a self-rating-scale for assessing general 
psychopathology and specific symptoms. The instrument is composed of 90 items, clustered 
into nine subscales: Somatization, Obsessive-Compulsive, Interpersonal Sensitivity, 
Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation and Psychoticism. 
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Individual distress can be specified for every item by a five-point-Likert-scale from 0 (“not at 
all”) through 4 (“extremely”). In the current study the total-score (GSI = Global Severity 
Index) served as indicator of general psychological distress. Further, we used the “Paranoid 
Ideation” (PAR) and “Psychoticism” (PSYC) subscales to explore psychosis-like symptoms. 
The item number of the PAR-subscale (5 items) was weighted on PSYC (7 items), and then 
both were summed up to generate the relevant dimension “Psychotic Symptoms” (SCL-90-R-
PS). In addition, for both general and psychotic symptoms the caseness definition of the 
checklist was used for separating individuals with elevated symptom levels from those with 
lower distress (Derogatis, 1977). Accordingly, individuals with scores ≥63 in the T-
transformed GSI-score as well as in both T-transformed subscale-scores of PSYC and PAR 
are considered as cases. Respondents exceeding a T-score of 70 on the general number of 
positive symptoms (item-score>0) on the checklist were excluded for suspected simulation 
(Derogatis (1977). 
In previous research the SCL-90-R was successfully used for detecting a disposition to 
psychosis (Henquet, et al., 2005) and as valid indicator of prodromal episodes (Jolley et al., 
1989). The PSYC and PAR scales have been used previously for assessing psychotic 
experiences in a general population sample (van der Werf et al., 2007) and as predictor of 
subsequent psychotic states (Wilson et al., 1985). The SCL-90-R is described as standard 
measure for a susceptibility to psychosis (Henquet et al., 2008).  
 
2.3. Statistical analyses 
For sample description means and standard deviations are presented for all considered 
variables. Gender differences were analyzed using t-tests, and associations with age were 
tested by Pearson correlations. 
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Group differences were analyzed using t-tests with a significance-level of p<0.005. 
Effect sizes (Cohen’s d) of group comparisons were provided as measures of external 
construct validity (Cohen, 1988). Associations between scale scores were tested by Pearson 
correlations. 
Further, hierarchic logistic regression analyses were run for GSI-caseness and PARA-/ 
PSYC-caseness. In both equations the ESI-subscales were controlled for initially, while the 
SPro (Total or Psy-Risk) was entered subsequently. This two-step approach provides 
evidence of the predictive power of the SPro. Odds ratio-estimates and 95%-confidence 
intervals were calculated. Next, receiver operating characteristic (ROC) analysis was used to 
assess the predictive validity of the SPro-Psy-Risk against PARA-/PSYC-caseness (Hsiao et 
al., 1989). The ROC-curve plots the true-positive against the false-positive rate for the 
different cut-points of the SPro. An adequate tradeoff between sensitivity and specificity and 
hence an optimal cut-off point indicating psychological distress was chosen. 
Analyses were carried out using STATA 10 for Macintosh (StataCorp, 2007). 
 
3. Results 
Table 1 presents means (±SDs) of the SCL-90-R’s GSI and PS, the SPro-Total and 
SPro-Psy-Risk as well as the ESI-subscales. Further, correlations of all measures analyzed in 
this study are shown. The high association of the SPro-Total with the SPro-Psy-Risk is 
artificial since the latter is a subscale of the SPro-Total. The same applies to the association 
between the GSI and PS. Very high associations are found for the intercorrelations of the ESI-
subscales, indicating strong dependence. SPro-Total and SPro-Psy-Risk show high 
correlations with the GSI and moderate associations with the SCL-90-R-PS. ESI-scales also 
show moderate correlations with the SCL-90-R-PS but lower level coefficients than the SPro. 
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The SPro-scales are moderately associated with all ESI-subscales. Associations with age were 
not significant (data not shown). 
 
-Insert Table 1- 
 
From the study sample 6.00% met caseness-criteria for general distress, whereas 
2.51% were considered as cases regarding psychotic symptoms (Table 2). Scores of SPro-
Total, SPro-Psy-Risk and ESI-subscales were significantly higher for cases than non-cases 
(both definitions) (p<0.001). Effect-sizes revealed best differentiation on the basis of the 
SPro, while ESI-subscales turned out to be lower (Table 2). 
 
-Insert Table 2- 
 
To assess the predictive validity of the SPro, hierarchic logistic regressions were 
calculated (Table 3). In the first sequence the predictability of general psychopathology was 
tested with GSI-caseness as dependent variable (Table 3, left section). The first model (model 
1) contains the ESI-scales as predictors only, while in a subsequent (model 2) the SPro-Total-
score was added. In model 1 two ESI-scales (AS and IR) significantly predicted caseness 
(aORs: 1.75 and 2.10), whereas solely the SPro-Total showed significant influence on the 
outcome (aOR: 3.48) when added to the equation (model 2).  
 The second sequence aimed at the prediction of caseness regarding psychotic 
symptoms as determined by SCL-90-R-PARA/PSYC (Table 3, right section). The ESI-
subscales failed to contribute to any of these models while both SPro-measures significantly 
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predicted caseness of psychotic symptoms after adjusting for ESI-measures (aORs: 2.68 and 
2.01). 
 
-Insert Table 3- 
 
The ROC-curve was plotted for the SPro-Psy-Risk to predict caseness on SCL-90-R-
PAR/PSYC (Figure 1). The area under the curve (AUC) was 0.74 (95% CI: 0.65-0.84), 
indicating the SPro-Psy-Risk to be a useful screening tool for being at risk for psychosis. 
With a cut-off of ≥2, a sensitivity of 73.91%, and a specificity of 61.40%, a positive 
predictive value of 4.70% and a negative predictive value of 98.90% was found. Altogether, 
61.75% of the sample (overall accuracy) was classified correctly, 38.57% non-cases were 
falsely assigned as being mentally distressed, and 26.09% true cases were missed by the 
SPro-Psy-risk. Prevalence-rates of subjects having a SPro-Psy-Risk-score ≥2 were 39.57%, 
which is large compared to the proportion of cases on PARA/PSYC (2.51%). All diagnostic 
information is summarized in Table 4. 
 
-Insert Figure 1- 
 
-Insert Table 4- 
 
 
4. Discussion 
The current study analyzes psychopathology with special emphasis on prodromal symptoms 
in a general population sample of young men. There is a growing body of evidence of (pre-) 
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psychotic symptoms to be present not only in clinical, but also in general population samples 
(van Os et al., 2000; Rössler et al., 2007). Some of these individuals were found to have 
higher probabilities for a transition to clinical states of psychosis (Poulton, et al., 2000). 
Although up to a third of the general population were found to experience one or more (pre-) 
psychotic symptoms, only a fractional amount is more narrowly definable as “psychotic case” 
(Kendler et al., 1996; van Os et al., 2000).  
The aim of the study was to evaluate a new economic self-report screening tool for 
assessing pre-psychotic symptoms (Selfscreen-Prodrome; SPro; Kammermann et al., 2009; 
Mueller et al., 2009). Therefore we defined caseness of psychotic distress as indicator for 
elevated stress levels. Similar prevalence as in the Dutch NEMESIS study were found (2.5% 
vs. 2.1%; van Os et al., 2000).  
The SPro showed sufficient psychometric properties and was found superior to 
existing self-ratings such as ESI-scales, to detect and predict general and pre-psychotic 
distress. Both forms of the SPro were highly correlated with the GSI and showed similar 
coefficients with psychotic pathology and the ESI-scales. That was according to expectation 
since the SPro was originally developed for the purpose of identifying early states of 
emerging psychotis although it covers a broad range of psychiatric symptoms. Group 
comparisons generally revealed significantly higher mean scores for cases than for non-cases 
in the SPro as well in the ESI scales. However, the SPro showed much higher effect sizes than 
the ESI-subscales, whereas the latter hardly exceeded the threshold for sufficient statistical 
power. Moreover, results from hierarchic logistic regressions support the advantage of the 
SPro over the ESI. While the SPro significantly predicted caseness in the final models ESI-
scales were not found to add any variance to these models. Initially two ESI-scales were 
slightly associated to GSI-caseness. 
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These findings are supported by the first study on the SPro (Kammermann et al., 
2009). Here the SPro distinguished well between healthy controls and mentally-ill patients 
(based on the SPro-Total) and psychosis-(risk)-patients as well (based on the subscale SPro-
Psy-Risk). Regarding the SPro-Psy-Risk the present study showed rather similar results in 
terms of the chosen cutoff  (≥2) and only a marginally lower specificity (61% vs. 66%).  
However, the sensitivity was lower (74% vs. 85%), probably due to a less reliable criterion 
(SCL-90-R cutoff compared to clinical caseness).  
Nevertheless, our results provide evidence for the diagnostic validity of the SPro as a 
screening tool for an increased risk of psychosis as a first step in the diagnostic process. 
However, caseness-rates (39.6%) derived from the SPro(-Psy-Risk) are higher than in the the 
PAR/PSYC-scales (2.5%). Screening via self-reports often overestimates the actual risk for 
subsequent psychosis. For example, Kendler et al. (1996) found that similarly high 
proportions (28.4%) of the cohort of the US-National-Comorbidity-Survey responded 
positively to probes, although less than 1% was actually diagnosed with psychotic illness. In a 
clinical re-interview Bak et al. (2005) found 40% false positives in a sample of subjects 
previously self-rated as high-risk, which is comparable to our study (38.6%). When screening 
for low prevalence disorders such as psychosis, the risk will always be overestimated in non-
clinical samples (O’Toole, 2000; Bak et al., 2005; Kendler et al., 1996). However, this is by 
definition what is intended with a screening tool. 
In summary, our findings suggest that the SPro is superior to the ESI in its diagnostic 
value on pre-psychotic states. Moreover, the SPro has the undeniable advantage of being a 
very short psychometric instrument (32 items), is easily scaled (0-/1-coded) and therefore 
much more economic than the ESI, especially when analyzing the subscale SPro-Psy-Risk (6 
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items). However, the results show that practicability and shortness involve decreased 
predictive performance. 
There are some limitations of our study. First, psychiatric "caseness" was 
operationalized using SCL-90-R subscales. Information about subsequent transitions to 
psychosis was not available. However, our operationalization derives from several 
investigations in different populations (Derogatis, 1977) and has proven to be empirically 
valid (Elsenbruch et al., 2006; Haas et al., 1999). Furthermore, group-specific SPro- and ESI-
scores reported in this study are highly comparable to previous studies, indicating an 
appropriate operationalization. Thus, caseness, especially that defined on psychotic 
dimensions, revealed similar ESI-scores as in schizophrenic samples (Mass et al., 2005; 2000; 
2001). In clinical samples as well as in healthy controls Kammermann and colleagues (2009) 
found comparable group mean-scores as in our study groups for both SPro-measures.  
 Although further replication is needed, the results of our study suggest that the SPro 
could be used successfully as valid and economic screening tool for at-risk mental states for 
psychosis. Such assessment must not be seen as a substitute for detailed clinical examinations 
and diagnostic processes but as an initial step. This type of initial screening may be very cost- 
and time-effective in identifying individuals with elevated risk for developing psychotic 
disorders or suffering from psychotic disorder already, especially in large population samples. 
A follow-up SPro-study with large conscript samples using genuine information about later 
transitions to psychosis is currently in process. 
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Table 1 
Correlations between SPro (Total and Psy-Risk), ESI and SCL-90-R PS  
 
 SPro-
Total 
SPro-
Psy-Risk 
ESI-AS ESI-AU ESI-IR ESI-DP SCL-
90-R 
PS 
SPro-Total 
(.22±.18) 
-       
SPro-Psy-
Risk 
(.24±.23) 
0.82*** -      
ESI-AS 
(.46±.46) 
0.48*** 0.40*** -     
ESI-AU 
(.47±46) 
0.39*** 0.34*** 0.73*** -    
ESI-IR 
(.35±.45) 
0.43*** 0.35*** 0.71*** 0.78*** -   
ESI-DP 
(.35±.42) 
0.42*** 0.36*** 0.75*** 0.80*** 0.83*** -  
SCL-90-R 
PS (0.44 
±0.38) 
0.52*** 0.43*** 0.33*** 0.32*** 0.39*** 0.36*** - 
*** p <0.001 
SPro-Total: Selfscreen-Prodrome 
SPro-Psy-Risk: Selfscreen-Prodrome subscale Psychotic Risk 
ESI-AS: ESI subscale Attention and Speech Impairment 
ESI-AU: ESI subscale Auditory Uncertainty 
ESI-IR: ESI subscale Ideas of Reference 
ESI-DP: ESI subscale Deviant Perception 
SCL-90-R PS: Symptom-Checklist-90-Revised Psychotic Symptoms 
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Table 2 
Comparisons of SPro (Total and Psy-Risk) and ESI scale scores of cases and non-cases regarding general and 
psychotic distress 
 
 
 
SPro-Total SPro-Psy-
risk 
ESI-AS ESI-AU ESI-IR ESI-DP 
SCL-90-R Global 
Severity Index 
Non-caseness 
(n=861, 94.00%) 
6.69±5.39 1.35±1.31 4.37±4.43 3.60±3.60 2.28±3.02 3.03±3.70 
Caseness (n=55, 
6.00%) 
14.67±6.59 2.98±1.42 8.55±5.71 6.04±4.43 4.85±4.23 5.51±4.14 
p > | t | <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Effect size 
(Cohen’s d) 
1.33 1.19 0.82 0.60 0.70 0.63 
SCL-90-R 
Psychotic 
Symptoms 
Non-caseness 
(n=892) 
6.99±5.64 1.41±1.36 4.54±4.59 3.69±3.65 2.38±3.09 3.11±3.75 
Caseness (n=23, 
2.51%) 
13.74±7.53 2.65±1.37 7.61±5.05 6.26±4.58 4.83±4.68 5.65±3.79 
p > | t | <0.001 <0.001 =0.002 =0.001 <0.001 =0.001 
Effect size 
(Cohen’s d)  
1.01 0.91 0.64 0.62 0.62 0.67 
Mean ± standard deviation 
SPro-Total: Selfscreen-Prodrome 
SPro-Psy-Risk: Selfscreen-Prodrome subscale Psychotic Risk 
ESI-AS: ESI subscale Attention and Speech Impairment 
ESI-AU: ESI subscale Auditory Uncertainty 
ESI-IR: ESI subscale Ideas of Reference 
ESI-DP: ESI subscale Deviant Perception 
SCL-90-R PS: Symptom-Checklist-90-Revised Psychotic Symptoms 
SCL-90-R GSI: Symptom-Checklist-90-Revised Global Severity Index 
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Table 3 
Hierarchic logistic regression models for general psychopathology (caseness vs. non) and psychotic dimension 
(caseness vs. non) 
 SCL-90-R GSI-caseness SCl-90-R PARA/PSYC-caseness 
 Model 1 Model 2 Model 1 Model 2a Model 2b 
ESI-AS 2.10 (1.39-3.18) 1.45 (0.95-2.22) 
n.s. 
1.20 (0.63-2.27) 
n.s. 
0.91 (0.49-1.68) 
n.s. 
1.02 (0.55-1.92) 
n.s. 
ESI-AU 0.83 (0.50-1.38) 
n.s. 
0.92 (0.54-1.54) 
n.s. 
1.15 (0.55-2.37) 
n.s. 
1.19 (0.58-2.47) 
n.s. 
1.14 (0.57-2.28) 
n.s. 
ESI-IR 1.75 (1.08-2.83) 1.59 (0.98-2.57) 
n.s. 
1.53 (0.76-3.07) 
n.s. 
1.36 (0.70-2.63) 
n.s. 
1.42 (0.72-2.83) 
n.s. 
ESI-DP 0.68 (0.40-1.15) 
n.s. 
0.60 (0.35-1.05) 
n.s. 
0.89 (.41-1.92) 
n.s. 
0.83 (0.39-1.80) 
n.s. 
0.89 (0.42-1.88) 
n.s. 
SPro-
Total 
 3.48 (2.42-5.00)  2.68 (1.65-4.36)  
SPro-
Psy-risk 
- -   2.01 (1.27-3.18) 
Independent variables are z-transformed.  
Values are odds ratios with 95% confidence intervals  
n.s.: non-significant p >0.05 
Values with p ≤0.05 are printed in bold 
SPro-Total: Selfscreen-Prodrome 
SPro-Psy-Risk: Selfscreen-Prodrome subscale Psychotic Risk 
ESI-AS: ESI subscale Attention and Speech Impairment 
ESI-AU: ESI subscale Auditory Uncertainty 
ESI-IR: ESI subscale Ideas of Reference 
ESI-DP: ESI subscale Deviant Perception 
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Table 4 
SPro-Psy-Risk: Results of the Receiver Operating Characteristic (ROC) on the PSYC-/PAR-definition of 
caseness and related diagnostic information 
 
 SPro-Psy-Risk 
AUC (95% confidence interval) 0.74 (0.65-0.84) 
Cutoff point ≥ 2 
Sensitivity 73.91% 
Specificity 61.43% 
Overall accuracy 61.75% 
Positive predictive value 4.70% 
Negative predictive value 98.90% 
False positive rate 38.57% 
False negative rate 26.09 
Prevalence rate by cutoff 39.57% 
AUC: Area under the curve  
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Figure 1 
Receiver Operating Characteristic (ROC) curve for the SPro-Psy-Risk scores as predictor of psychotic caseness  
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Many people develop psychological problems during the course of their lives. Often, these problems 
are caused by stress and once the stress has passed, the problem will resolve. In some cases, 
however, a person’s character and abilities can change to such an extent that he or she is “no longer 
the same person”.  
Please mark all permanent changes that you have experienced for the first time in the last few years. 
    
    
  true not true  
1.  Increased sensitivity, more easily moved   
2.  Over-sensitivity, more easily hurt or upset   
3.  Irritability   
4.  Being short-tempered   
5.  Nervousness, feeling tense   
6.  Disturbed sleep   
7.  Lack of energy, drive, initiative or interest   
8.  Suspiciousness   
9.  Anxiety   
10.  Feeling depressed   
11.  Blunted emotions   
12.  Pronounced mood swings   
13.  Difficulties concentrating   
14.  More easily distracted   
15.  Lower level of resilience   
16.  Changes in interests   
      (e.g. unusual interest in religion and supernatural matters) 
17.  Changes in perception   
       (e.g. hearing, seeing, smelling or tasting unusual things) 
18.  Relating events to oneself   
19.  Feeling observed, harmed or threatened   
20.  Feeling controlled or influenced by others   
21.  Unusual difficulties with relationships   
22.  Withdrawing from others, isolating oneself   
23.  Changes in behaviour   
      (e.g. loud soliloquy in public)   
24.  Other people have mentioned changes in the way I speak   
 (e.g. my speech has become difficult to understand) 
25.  Marked decline in performance, possibly with difficulties   
        at work or school 
26.  Neglecting jobs and duties   
27.  Professional decline   
28.  Loss of job/dropping out of vocational training   
29.  Increased problems with relationships   
       (partner, family, work) 
30.  Beginning to take drugs regularly   
       (alcohol, cannabis, cocaine, opiates or tranquilizers) 
31.  Previous psychiatric or psychological treatment   
32.  Finally we would like to ask you some questions about your family. 
       Are there any mental disorders in your family? 
       Yes    
 No     
 I don’t know   
 
Please check that you have answered all the questions and have not missed any! 
 
